Adaptive Biotechnologies Corporation (ADPT)
Company Info
| ISIN | US00650F1093 |
|---|---|
| CUSIP | 00650F109 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $684.27M |
|---|---|
| EPS (TTM) | -$1.47 |
| Total Revenue (TTM) | $130.85M |
| Gross Profit (TTM) | $65.69M |
| EBITDA (TTM) | -$114.00M |
| Year Range | $2.28 - $5.80 |
| Target Price | $7.30 |
| Short % | 8.63% |
| Short Ratio | 9.16 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: ADPT vs. SPY, ADPT vs. MU
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Adaptive Biotechnologies Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Adaptive Biotechnologies Corporation had a return of -4.49% year-to-date (YTD) and 14.71% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -4.49% | 22.95% |
| 1 month | 1.52% | 4.39% |
| 6 months | 95.00% | 18.07% |
| 1 year | 14.71% | 37.09% |
| 5 years (annualized) | -30.74% | 14.48% |
| 10 years (annualized) | N/A | 11.71% |
Monthly Returns
The table below presents the monthly returns of ADPT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -25.10% | 11.99% | -21.90% | -18.38% | 31.68% | 4.93% | 25.69% | 3.30% | 8.94% | -4.49% | |||
| 2023 | 21.34% | -7.77% | 3.27% | -19.14% | -2.52% | -3.59% | 25.78% | -19.79% | -19.50% | -18.53% | -1.35% | 11.87% | -35.86% |
| 2022 | -37.85% | -17.26% | -3.81% | -40.56% | -5.21% | 3.45% | 13.23% | -2.62% | -20.18% | 9.27% | 12.85% | -12.98% | -72.77% |
| 2021 | -6.19% | 1.98% | -28.83% | 3.33% | -9.11% | 8.07% | -10.28% | -0.93% | -6.42% | -1.71% | -21.91% | 7.55% | -52.55% |
| 2020 | -0.05% | -6.04% | -1.14% | 15.23% | 20.90% | 25.01% | -22.86% | 11.50% | 16.87% | -5.24% | 4.64% | 22.63% | 97.63% |
| 2019 | 19.85% | -20.19% | 31.91% | -39.23% | -15.65% | 4.32% | 10.04% | -25.76% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ADPT is 45, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Adaptive Biotechnologies Corporation (ADPT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Adaptive Biotechnologies Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Adaptive Biotechnologies Corporation was 96.55%, occurring on Apr 18, 2024. The portfolio has not yet recovered.
The current Adaptive Biotechnologies Corporation drawdown is 93.09%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.55% | Jan 25, 2021 | 814 | Apr 18, 2024 | — | — | — |
| -68.3% | Sep 5, 2019 | 133 | Mar 16, 2020 | 188 | Dec 10, 2020 | 321 |
| -27.29% | Jul 1, 2019 | 25 | Aug 5, 2019 | 18 | Aug 29, 2019 | 43 |
| -14.85% | Dec 24, 2020 | 7 | Jan 5, 2021 | 7 | Jan 14, 2021 | 14 |
| -2.05% | Dec 15, 2020 | 1 | Dec 15, 2020 | 2 | Dec 17, 2020 | 3 |
Volatility
Volatility Chart
The current Adaptive Biotechnologies Corporation volatility is 26.73%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Adaptive Biotechnologies Corporation.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |